ARELIS RIVERA: Open Payments
NPI 1003262353 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 17 payments from 11 companies in 2025. Trend: 2023 $301 · 2024 $286 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Dendreon Pharmaceuticals LLC | 1 | $118 |
| Janssen Scientific Affairs, LLC | 2 | $77 |
| Novartis Pharmaceuticals Corporation | 3 | $64 |
| Daiichi Sankyo Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 1 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Blue Earth Diagnostics | 1 | $24 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: PROVENGE, ERLEADA, PLUVICTO, ENHERTU, GEMTESA, REZUROCK, Nubeqa, DATROWAY.
Industry payments across FL — which companies pay providers there.
